GEROTHERAPEUTIX, Inc.
PrivateLast Round
VC Round
Jun 17, 2026
Total Funding Raised
$17M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GEROTHERAPEUTIX, Inc. is a biotechnology company developing gerotherapeutics aimed at targeting the underlying biological processes of aging to improve healthspan.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GEROTHERAPEUTIX, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
GEROTHERAPEUTIX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 17, 2026 | ||||
| Convertible Debt | Mar 26, 2026 | ||||
| Series A Extension | Oct 18, 2023 | ||||
| Series A | Aug 4, 2020 | ||||
| Seed | May 1, 2019 |
GEROTHERAPEUTIX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rapha Capital Management | Convertible Debt |
| VitaDAO | Series A Extension |
| Melnichek Investments | VC Round, Series A Extension |
| Bulba Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
$17M raised with participation from Leonid Lozner and Melnichek Investments.
- Mar 26, 2026
$18M round led by Rapha Capital Management
GEROTHERAPEUTIX, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GEROTHERAPEUTIX, Inc.'s valuation, stock price, and market status.